Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

AGIO Agios Pharmaceuticals Inc

35,00

-0,18 (-0,51%)

17 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Agios Pharmaceuticals Charts.

Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Agios Pharmaceuticals Charts.

News Agios Pharmaceuticals Inc

Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress
Dienstag 14 Mai 2024 (3 Tage vor) • GlobeNewswire Inc.

Agios to Present at the BofA Securities 2024 Health Care Conference on May 16, 2024
Montag 6 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024
Freitag 3 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Agios Reports Business Highlights and First Quarter 2024 Financial Results
Donnerstag 2 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024
Donnerstag 18 April 2024 (4 Wochen vor) • GlobeNewswire Inc.

Agios Publishes 2024 Environmental, Social and Governance (ESG) Report
Dienstag 9 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 8 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 5 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Agios Pharmaceuticals Inc News-Artikel

Simplify ETFs Simplify N...

Westwater Resources

Artificial Liquid Intelligence T

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen